The global 3D printed drugs market is anticipated to grow at a CAGR of 9.1% during the forecast period. 3D printing as a technique is now well-established and commonly used in industries such as automotive, healthcare (particularly in dental and orthopedic fields), and retail. 3D printed drugs are used to fuel innovation and progress across pharmaceutical industries. 3D-printed drugs may be useful for orphan drugs and/or personalized medications as these drugs are produced in a small amount. However, the first FDA- approved drug was developed on a commercial scale in August 2015. Spritam (levetiracetam), the first 3D printed medication, was launched by Aprecia Pharmaceuticals. It uses a specially designed platform to manufacture quickly dissolving high-dose medications that are safe to chew.

Free Sample Copy @ https://www.omrglobal.com/request-sample/3d-printed-drugs-market

The market for 3D printed drugs is being driven by the drawbacks of traditional pharmaceutical unit operations across the globe. For instance, traditional manufacturing unit operations such as milling, grinding, granulation, and compression can result in a wide range of final product qualities in terms of drug loading, drug release, drug stabilization, and pharmaceutical dosage form stability. 3D printed drugs are being developed in such a way that they do not alter the qualities of the final product.

A Full Report of Global 3D Printed Drugs Market is Available at:
https://www.omrglobal.com/industry-reports/3d-printed-drugs-market

The global 3D printed drugs market is segmented based on dosage form, technology, and region. Based on dosage form, the market is segmented into a tablet, capsules, multi-drug implant, nanoparticles, solutions, nanosuspension, encapsulated within a polymer, and implant. Among dosage forms, the tablet market is anticipated to grow at a significant CAGR during the forecast period. Further, based on technology, the market is classified into inkjet printing, zip dose, fused deposition modeling (FDM), and stereolithography (SLA), and others. Apart from this, based on the application, the market is classified into dental, hearing & audibility aid, medical implants, neurology, and orthopedic. In 2019, the neurology 3D printed drugs segment held a major market share.

Global 3D Printed Drugs Market – Segmentation
By Dosage Forms
Tablet
Capsules
Multi-Drug Implant
Nanoparticles
Solutions
Nano suspension
Encapsulated within a polymer
Implant
By Technology
Inkjet Printing
Zip Dose
Fused Deposition Modelling (FDM)
Stereolithography (SLA)
Others (Direct-Write, powder bed printing)
By Application
Dental
Hearing & Audibility Aid
Medical Implants
Neurology
Orthopedic

Global 3D Printed Drugs Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
3D Systems Corp.
Anatomics Pty Ltd
Aprecia Pharmaceuticals, LLC
Cycle Pharmaceuticals Ltd.
FabRx Ltd.
AstraZeneca Plc
Biomedical Modeling Inc.,
CELLINK AB
EnvisionTEC GmbH
GlaxoSmithKline Plc
Linx Printing Technologies
Materialise NV
Merck KGaA
Organovo Holdings, Inc.
Pharma Excipients International AG
PreScouter, Inc.
Prodways Group SA
Renishaw PLC
Siemens AG
SLM Solutions Group AG
Stratasys Ltd.,
Yissum
Zortrax SA

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/3d-printed-drugs-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404